Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03411577 |
Recruitment Status :
Completed
First Posted : January 26, 2018
Last Update Posted : January 26, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Parent-Child Relations HIV Prevention Adolescent Behavior | Other: Behavioral Intervention | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 662 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Mother-daughter dyads were randomly assigned to either HIV risk-reduction intervention group or control group |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Data collectors were unaware of group assignment of participants. |
Primary Purpose: | Prevention |
Official Title: | Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program |
Actual Study Start Date : | September 29, 2007 |
Actual Primary Completion Date : | July 28, 2011 |
Actual Study Completion Date : | June 30, 2012 |
Arm | Intervention/treatment |
---|---|
Experimental: Behavioral Intervention
The adolescent HIV/STI risk-reduction intervention aims to: (a) increase knowledge of HIV risk and prevention; (b) strengthen behavioral beliefs regarding abstinence and safer sex; (c) increase self-efficacy and intentions to avoid unsafe sex; and (d) increase sexual communication and refusal skills. The mother component includes much of the same prevention knowledge and addresses parent-teen sexual risk communication, monitoring, and sexual role modeling. Interventions are held on two consecutive Saturdays for 6 hours each day. Mothers' groups meet separately from daughters' groups, although the groups will come together for the last module of each day.
|
Other: Behavioral Intervention |
No Intervention: Control Group
The control / comparison group is essentially a "no intervention / wait-list" control group. However, during pilot testing, participants expressed a strong desire to engage in some type of health activity. As a result, the control group members, both mothers and daughters, participated in a brief educational activity on reducing risk for cardiovascular disease. The educational activity was limited to a few hours on one Saturday. Participants returned the following week to complete post-test questionnaires along with the participants in the experimental group.
|
- Change in adolescent girls' baseline self-reported frequency of condom use at 3 and 6 months [ Time Frame: Assessed at baseline, 3- and 6-months; reported for past 3 months ]Questionnaire - self-reported single item asking frequency of condom use during past 3 months; scores range from 1 - 5; higher scores indicate greater frequency of condom use
- Adolescent girls' clinically documented STIs [ Time Frame: Assessed at baseline and 6-month follow-up ]Urine pcr tests for chlamydia and gonorrhea
- Change in adolescent girls' baseline self-reported condom use intentions at 3 and 6 months [ Time Frame: Assessed at baseline, 3- and 6-months; reported for next 3 months ]Questionnaire - self-reported single item asking intentions to use condoms during next 3 months; scores range from 1 to 5; higher scores indicate greater intentions
- Change in adolescent girls' baseline HIV knowledge scale scores at 3 and 6 months [ Time Frame: Assessed at baseline and 3- and 6-month follow-up ]Questionnaire - HIV/AIDS Knowledge Scale - 19 items; scores range from 0 - 19 with higher scores indicating greater amounts of knowledge
- Changes in mothers' baseline HIV knowledge scale scores at 3 and 6 months [ Time Frame: Assessed at baseline and 3- and 6-month follow-up ]Questionnaire - HIV/AIDS Knowledge Scale - 19 items; scores range from 0 - 19 with higher scores indicating greater amounts of knowledge
- Change in mothers' baseline parental monitoring scale scores at 3 and 6 months [ Time Frame: Assessed at baseline and 3- and 6-month follow-up; reported for past 3 months ]Questionnaire - self-reported 10-item scale of parental monitoring reported by daughters ; total scores range from 10 - 50; higher scores indicate more parental monitoring/supervision
- Change in adolescent girls' baseline parent-teen sexual risk communication (PTSRC) scale scores at 3 and 6 months [ Time Frame: Assessed at baseline and 3- and 6-month follow-up; reported for past 3 months ]Questionnaire - PTSRC-III scale; 8 items; total scores range from 5 - 40; higher scores indicate greater sexual communication

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 13 Years to 17 Years (Child) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Inclusion criteria for the adolescent include:
- age between 13- to 17-years, inclusive
- resident of one of the three parishes in and around Kingston, Jamaica (the study area)
- plan to reside in the "study area" for the next 12 months
- able to read, write and understand English
- unmarried and
- agrees to participate and
- mother or primary female guardian also agrees to participate.
Inclusion criteria for the mother/female guardian include:
- age greater than 18
- resident of one of the three parishes in and around Kingston, Jamaica (the study area)
- plan to reside in the "study area" for the next 12 months
- able to read, write and understand English and
- agrees to participate
Exclusion Criteria:
- adolescent and/or mother who is/are disruptive and/or otherwise unable to participate in small group intervention activities
- adolescent who is married

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03411577
Principal Investigator: | Mary K Hutchinson, PhD | Boston College |
Other Publications:
Responsible Party: | Mary Katherine Hutchinson, Professor, Boston College |
ClinicalTrials.gov Identifier: | NCT03411577 |
Other Study ID Numbers: |
R01NR010478 ( U.S. NIH Grant/Contract ) |
First Posted: | January 26, 2018 Key Record Dates |
Last Update Posted: | January 26, 2018 |
Last Verified: | January 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Decisions regarding data sharing will be made on a case-by-case basis. Those who would like to request data should contact the principal investigator. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |